{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T08:41:28Z","timestamp":1792917688695,"version":"4.5.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T00:00:00Z","timestamp":1676073600000},"content-version":"am","delay-in-days":225,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ajo.2022.01.020","type":"journal-article","created":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T01:53:34Z","timestamp":1644544414000},"page":"74-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Role of Caspase-1 as a Biomarker of Ocular Surface Damage"],"prefix":"10.1016","volume":"239","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2295-3104","authenticated-orcid":false,"given":"Arianna","family":"Tovar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1312-3064","authenticated-orcid":false,"given":"Andres","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maricarmen Perez","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3026-6155","authenticated-orcid":false,"given":"Anat","family":"Galor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7198-6602","authenticated-orcid":false,"given":"Swarup S.","family":"Swaminathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5460-8834","authenticated-orcid":false,"given":"Juan Pablo","family":"de Rivero Vaccari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6383-2558","authenticated-orcid":false,"given":"Alfonso L.","family":"Sabater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ajo.2022.01.020_bib0001","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","article-title":"TFOS DEWS II pathophysiology report","volume":"15","author":"Bron","year":"2017","journal-title":"Ocul Surf"},{"issue":"5","key":"10.1016\/j.ajo.2022.01.020_bib0002","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/ACI.0b013e32834a95c9","article-title":"Ocular surface damage by ophthalmic compounds","volume":"11","author":"Mantelli","year":"2011","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.ajo.2022.01.020_bib0003","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II Definition and Classification Report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.ajo.2022.01.020_bib0004","doi-asserted-by":"crossref","first-page":"P286","DOI":"10.1016\/j.ophtha.2018.10.023","article-title":"Dry eye syndrome preferred practice pattern (R)","volume":"126","author":"Akpek","year":"2019","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2022.01.020_bib0005","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/ICL.0000000000000643","article-title":"A new perspective on dry eye classification: proposal by the Asia Dry Eye Society","volume":"46","author":"Tsubota","year":"2020","journal-title":"Eye Contact Lens"},{"issue":"23","key":"10.1016\/j.ajo.2022.01.020_bib0006","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1056\/NEJMra1407936","article-title":"Dry eye","volume":"378","author":"Clayton","year":"2018","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ajo.2022.01.020_bib0007","first-page":"351","article-title":"Ocular graft versus host disease following allogeneic stem cell transplantation: a review of current knowledge and recommendations","volume":"8","author":"Nassiri","year":"2013","journal-title":"J Ophthalmic Vis Res"},{"key":"10.1016\/j.ajo.2022.01.020_bib0008","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1749-6632.2002.tb04217.x","article-title":"Androgen deficiency, meibomian gland dysfunction, and evaporative dry eye","volume":"966","author":"Sullivan","year":"2002","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.ajo.2022.01.020_bib0009","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/GME.0000000000000530","article-title":"Dry eye in postmenopausal women: a hormonal disorder","volume":"23","author":"Sriprasert","year":"2016","journal-title":"Menopause"},{"issue":"9","key":"10.1016\/j.ajo.2022.01.020_bib0010","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/OPX.0b013e3181852777","article-title":"Impact of floppy eyelid syndrome in ocular surface and dry eye disease","volume":"85","author":"Mastrota","year":"2008","journal-title":"Optom Vis Sci"},{"issue":"2","key":"10.1016\/j.ajo.2022.01.020_bib0011","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/archopht.1995.01100020037025","article-title":"Effects of ocular surface area and blink rate on tear dynamics","volume":"113","author":"Tsubota","year":"1995","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2022.01.020_bib0012","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1097\/ICO.0000000000002152","article-title":"Risk factors for dry eye after refractive surgery","volume":"38","author":"Shehadeh-Mashor","year":"2019","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.ajo.2022.01.020_bib0013","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1542-0124(12)70150-7","article-title":"The contribution of meibomian disease to dry eye","volume":"2","author":"Bron","year":"2004","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.ajo.2022.01.020_bib0014","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/PRS.0b013e318272a00e","article-title":"Pharmaceutical and herbal products that may contribute to dry eyes","volume":"131","author":"Askeroglu","year":"2013","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ajo.2022.01.020_bib0015","first-page":"2131","article-title":"Preservative toxicity in glaucoma medication: clinical evaluation of benzalkonium chloride-free 0.5% timolol eye drops","volume":"7","author":"Rosin","year":"2013","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2022.01.020_bib0016","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0161-6420(99)90116-1","article-title":"Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies","volume":"106","author":"Baudouin","year":"1999","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2022.01.020_bib0017","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/ICU.0b013e32835c8aba","article-title":"Glaucoma therapy and ocular surface disease: current literature and recommendations","volume":"24","author":"Anwar","year":"2013","journal-title":"Curr Opin Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2022.01.020_bib0018","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s12886-021-02079-y","article-title":"Impact of dorzolamide, benzalkonium-preserved dorzolamide and benzalkonium-preserved brinzolamide on selected biomarkers of oxidative stress in the tear film","volume":"21","author":"Sedlak","year":"2021","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2022.01.020_bib0019","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12886-021-01917-3","article-title":"Dry eye disease among glaucoma patients on topical hypotensive medications, in a tertiary hospital, Ethiopia","volume":"21","author":"Sahlu","year":"2021","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2022.01.020_bib0020","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1177\/112067210901900409","article-title":"Dry eye syndrome-related quality of life in glaucoma patients","volume":"19","author":"Rossi","year":"2009","journal-title":"Eur J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2022.01.020_bib0021","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jfo.2011.07.011","article-title":"Corneal sensitivity in patients treated medically for glaucoma or ocular hypertension]. Evaluation de la sensibilite corneenne chez les patients traites medicalement pour un glaucome ou une hypertonie oculaire","volume":"34","author":"Van Went","year":"2011","journal-title":"J Fr Ophtalmol"},{"issue":"6","key":"10.1016\/j.ajo.2022.01.020_bib0022","first-page":"931","article-title":"Ocular surface evaluation in eyes with chronic glaucoma on long term topical antiglaucoma therapy","volume":"10","author":"Saini","year":"2017","journal-title":"Int J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2022.01.020_bib0023","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/08830185.2012.748052","article-title":"Dry eye as a mucosal autoimmune disease","volume":"32","author":"Stern","year":"2013","journal-title":"Int Rev Immunol"},{"issue":"2","key":"10.1016\/j.ajo.2022.01.020_bib0024","first-page":"240","article-title":"Dry eye: an inflammatory ocular disease","volume":"9","author":"Hessen","year":"2014","journal-title":"J Ophthalmic Vis Res"},{"issue":"3","key":"10.1016\/j.ajo.2022.01.020_bib0025","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4155\/cli.14.135","article-title":"Cyclosporine ophthalmic emulsions for the treatment of dry eye: a review of the clinical evidence","volume":"5","author":"Ames","year":"2015","journal-title":"Clin Investig (Lond)"},{"key":"10.1016\/j.ajo.2022.01.020_bib0026","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2147\/OPTH.S126668","article-title":"Dry eye syndrome: developments and lifitegrast in perspective","volume":"12","author":"Lollett","year":"2018","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2022.01.020_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126277","article-title":"Upregulation of NLRP3 inflammasome in the tears and ocular surface of dry eye patients","volume":"10","author":"Niu","year":"2015","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.ajo.2022.01.020_bib0028","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.ajo.2022.01.020_bib0029","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1189\/jlb.3MR0617-250R","article-title":"Molecular mechanisms of inflammasome signaling","volume":"103","author":"Mathur","year":"2018","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.ajo.2022.01.020_bib0030","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.expneurol.2014.01.001","article-title":"Pattern recognition receptors and central nervous system repair","volume":"258","author":"Kigerl","year":"2014","journal-title":"Exp Neurol"},{"issue":"1","key":"10.1016\/j.ajo.2022.01.020_bib0031","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s12974-020-01944-9","article-title":"Role of inflammasomes in multiple sclerosis and their potential as therapeutic targets","volume":"17","author":"Govindarajan","year":"2020","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.ajo.2022.01.020_bib0032","series-title":"Activation of NFkB and NLRP3 inflammasome in the corneal epithelium following shot-term desiccating stress","author":"Zhiyuan Yu","year":"2021"},{"key":"10.1016\/j.ajo.2022.01.020_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exer.2014.05.001","article-title":"Reactive oxygen species activated NLRP3 inflammasomes prime environment-induced murine dry eye","volume":"125","author":"Zheng","year":"2014","journal-title":"Exp Eye Res"},{"issue":"4","key":"10.1016\/j.ajo.2022.01.020_bib0034","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jtos.2020.07.001","article-title":"NLRP12- and NLRC4-mediated corneal epithelial pyroptosis is driven by GSDMD cleavage accompanied by IL-33 processing in dry eye","volume":"18","author":"Chen","year":"2020","journal-title":"Ocul Surf"},{"issue":"11","key":"10.1016\/j.ajo.2022.01.020_bib0035","doi-asserted-by":"crossref","first-page":"8442","DOI":"10.1167\/iovs.11-8152","article-title":"Neurodegenerative and inflammatory pathway components linked to TNF-alpha\/TNFR1 signaling in the glaucomatous human retina","volume":"52","author":"Yang","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"30","key":"10.1016\/j.ajo.2022.01.020_bib0036","doi-asserted-by":"crossref","first-page":"11181","DOI":"10.1073\/pnas.1402819111","article-title":"Caspase-8 promotes NLRP1\/NLRP3 inflammasome activation and IL-1beta production in acute glaucoma","volume":"111","author":"Chi","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.ajo.2022.01.020_bib0037","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.exer.2006.02.004","article-title":"Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye","volume":"83","author":"De Paiva","year":"2006","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ajo.2022.01.020_bib0038","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.2147\/OPTH.S121256","article-title":"Presence or absence of ocular surface inflammation directs clinical and therapeutic management of dry eye","volume":"10","author":"Sambursky","year":"2016","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2022.01.020_bib0039","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/archophthalmol.2009.356","article-title":"Minimal clinically important difference for the ocular surface disease index","volume":"128","author":"Miller","year":"2010","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2022.01.020_bib0040","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.1167\/iovs.11-9054","article-title":"Evaluations of tear protein markers in dry eye disease: repeatability of measurement and correlation with disease","volume":"53","author":"Huang","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.ajo.2022.01.020_bib0041","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1167\/tvst.8.6.34","article-title":"Assessment of corneal fluorescein staining in different dry eye subtypes using digital image analysis","volume":"8","author":"Pellegrini","year":"2019","journal-title":"Transl Vis Sci Technol"},{"issue":"5","key":"10.1016\/j.ajo.2022.01.020_bib0042","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.ajo.2014.02.012","article-title":"Reliability of 4 clinical grading systems for corneal staining","volume":"157","author":"Sook Chun","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2022.01.020_bib0043","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1046\/j.1475-1313.2001.00575.x","article-title":"Grading scales for contact lens complications","volume":"18","author":"Efron","year":"1998","journal-title":"Ophthalmic Physiol Opt"},{"issue":"2","key":"10.1016\/j.ajo.2022.01.020_bib0044","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jtos.2015.10.004","article-title":"The matrix metalloproteinase 9 point-of-care test in dry eye","volume":"14","author":"Lanza","year":"2016","journal-title":"Ocul Surf"},{"issue":"2","key":"10.1016\/j.ajo.2022.01.020_bib0045","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jtos.2019.01.004","article-title":"Review and analysis of grading scales for ocular surface staining","volume":"17","author":"Begley","year":"2019","journal-title":"Ocul Surf"},{"issue":"10","key":"10.1016\/j.ajo.2022.01.020_bib0046","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8101627","article-title":"Total tear IgE levels correlate with allergenic and irritating environmental exposures in individuals with dry eye","volume":"8","author":"Dermer","year":"2019","journal-title":"J Clin Med"},{"issue":"7","key":"10.1016\/j.ajo.2022.01.020_bib0047","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235408","article-title":"Importance of tear volume for positivity of tear matrix metalloproteinase-9 immunoassay","volume":"15","author":"Jun","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ajo.2022.01.020_bib0048","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/ICO.0000000000002096","article-title":"Changes in the matrix metalloproteinase 9 point-of-care test positivity according to MMP-9 concentration and loading volume","volume":"39","author":"Huh","year":"2020","journal-title":"Cornea"},{"issue":"13","key":"10.1016\/j.ajo.2022.01.020_bib0049","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1167\/tvst.9.13.27","article-title":"Inflammasome proteins as inflammatory biomarkers of age-related macular degeneration","volume":"9","author":"Weaver","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.ajo.2022.01.020_bib0050","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.3389\/fphar.2020.01238","article-title":"The Inflammasome signaling proteins ASC and IL-18 as biomarkers of psoriasis","volume":"11","author":"Forouzandeh","year":"2020","journal-title":"Front Pharmacol"},{"issue":"22","key":"10.1016\/j.ajo.2022.01.020_bib0051","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228580","article-title":"IL-18 and Galectin-3 as biomarkers of non-alcoholic steatohepatitis: a proof of concept study","volume":"21","author":"Cyr","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"13","key":"10.1016\/j.ajo.2022.01.020_bib0052","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21134674","article-title":"The inflammasome adaptor protein ASC in mild cognitive impairment and alzheimer's disease","volume":"21","author":"Scott","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajo.2022.01.020_bib0053","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3389\/fnmol.2018.00309","article-title":"Inflammasome proteins in serum and serum-derived extracellular vesicles as biomarkers of stroke","volume":"11","author":"Kerr","year":"2018","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.ajo.2022.01.020_bib0054","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fneur.2018.00135","article-title":"Inflammasome proteins as biomarkers of multiple sclerosis","volume":"9","author":"Keane","year":"2018","journal-title":"Front Neurol"},{"issue":"6","key":"10.1016\/j.ajo.2022.01.020_bib0055","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3171\/2012.9.JNS12815","article-title":"Inflammasome proteins in cerebrospinal fluid of brain-injured patients as biomarkers of functional outcome: clinical article","volume":"117","author":"Adamczak","year":"2012","journal-title":"J Neurosurg"},{"issue":"12","key":"10.1016\/j.ajo.2022.01.020_bib0056","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210128","article-title":"Inflammasome proteins as biomarkers of traumatic brain injury","volume":"13","author":"Kerr","year":"2018","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ajo.2022.01.020_bib0057","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.neuron.2018.08.001","article-title":"Defective inflammatory pathways in never-treated depressed patients are associated with poor treatment response","volume":"99","author":"Syed","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.ajo.2022.01.020_bib0058","first-page":"1","article-title":"Levels of caspase-1 in cerebrospinal fluid of patients with traumatic brain injury: correlation with intracranial pressure and outcome","author":"Perez-Barcena","year":"2020","journal-title":"J Neurosurg"},{"issue":"11","key":"10.1016\/j.ajo.2022.01.020_bib0059","doi-asserted-by":"crossref","DOI":"10.3390\/nu11112792","article-title":"Polydatin Inhibits NLRP3 inflammasome in dry eye disease by attenuating oxidative stress and inhibiting the NF-kappaB pathway","volume":"11","author":"Park","year":"2019","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.ajo.2022.01.020_bib0060","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1167\/iovs.04-0041","article-title":"Caspase-1 inhibitor reduces severity of Pseudomonas aeruginosa keratitis in mice","volume":"45","author":"Thakur","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.ajo.2022.01.020_bib0061","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/ICU.0000000000000569","article-title":"Advances in dry eye disease treatment","volume":"30","author":"O'Neil","year":"2019","journal-title":"Curr Opin Ophthalmol"},{"issue":"11S","key":"10.1016\/j.ajo.2022.01.020_bib0062","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.ophtha.2017.08.029","article-title":"Inflammation in dry eye disease: how do we break the cycle?","volume":"124","author":"Rhee","year":"2017","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2022.01.020_bib0063","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/jcbfm.2013.227","article-title":"Activation and regulation of cellular inflammasomes: gaps in our knowledge for central nervous system injury","volume":"34","author":"de Rivero Vaccari","year":"2014","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"10.1016\/j.ajo.2022.01.020_bib0064","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/jcbfm.2013.236","article-title":"Pyroptotic neuronal cell death mediated by the AIM2 inflammasome","volume":"34","author":"Adamczak","year":"2014","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"10.1016\/j.ajo.2022.01.020_bib0065","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1600-065X.2011.01044.x","article-title":"Caspase-1-induced pyroptotic cell death","volume":"243","author":"Miao","year":"2011","journal-title":"Immunol Rev"},{"issue":"8","key":"10.1016\/j.ajo.2022.01.020_bib0066","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/ni.2919","article-title":"The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response","volume":"15","author":"Baroja-Mazo","year":"2014","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.ajo.2022.01.020_bib0067","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/eye.2017.241","article-title":"Inflammasomes, the eye and anti-inflammasome therapy","volume":"32","author":"Yerramothu","year":"2018","journal-title":"Eye (Lond)"},{"issue":"9","key":"10.1016\/j.ajo.2022.01.020_bib0068","doi-asserted-by":"crossref","first-page":"e74010","DOI":"10.1371\/journal.pone.0074010","article-title":"Staphylococcus aureus activates the NLRP3 inflammasome in human and rat conjunctival goblet cells","volume":"8","author":"McGilligan","year":"2013","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.ajo.2022.01.020_bib0069","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1523\/JNEUROSCI.0157-08.2008","article-title":"A molecular platform in neurons regulates inflammation after spinal cord injury","volume":"28","author":"de Rivero Vaccari","year":"2008","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.ajo.2022.01.020_bib0070","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1113\/expphysiol.2012.069021","article-title":"The heart on fire: inflammasome and cardiomyopathy","volume":"98","author":"Abbate","year":"2013","journal-title":"Exp Physiol"},{"key":"10.1016\/j.ajo.2022.01.020_bib0071","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvab202","article-title":"AIM2-driven inflammasome activation in heart failure","author":"Onodi","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ajo.2022.01.020_bib0072","doi-asserted-by":"crossref","DOI":"10.1111\/jgh.15561","article-title":"Role of the inflammasome, gasdermin D, and pyroptosis in non-alcoholic fatty liver disease","author":"Rodriguez-Antonio","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.ajo.2022.01.020_bib0073","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.juro.2014.11.093","article-title":"Activation of the NLRP3 inflammasome in association with calcium oxalate crystal induced reactive oxygen species in kidneys","volume":"193","author":"Joshi","year":"2015","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.ajo.2022.01.020_bib0074","doi-asserted-by":"crossref","first-page":"329","DOI":"10.5483\/BMBRep.2020.53.6.065","article-title":"The activation of NLRP3 inflammasome potentiates the immunomodulatory abilities of mesenchymal stem cells in a murine colitis model","volume":"53","author":"Ahn","year":"2020","journal-title":"BMB Rep"},{"key":"10.1016\/j.ajo.2022.01.020_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108574","article-title":"Tumor necrosis factor-alpha and interferon-gamma induce inflammasome-mediated corneal endothelial cell death","volume":"207","author":"Gomez","year":"2021","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ajo.2022.01.020_bib0076","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.preteyeres.2014.10.001","article-title":"Clinical staining of the ocular surface: mechanisms and interpretations","volume":"44","author":"Bron","year":"2015","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"10.1016\/j.ajo.2022.01.020_bib0077","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","article-title":"Preservatives in eyedrops: the good, the bad and the ugly","volume":"29","author":"Baudouin","year":"2010","journal-title":"Prog Retin Eye Res"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939422000368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939422000368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:48:46Z","timestamp":1757598526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939422000368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":77,"alternative-id":["S0002939422000368"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2022.01.020","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Caspase-1 as a Biomarker of Ocular Surface Damage","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2022.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}